A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)

NCT00648648 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: adavosertib
DRUG: gemcitabine
DRUG: cisplatin
DRUG: carboplatin

Sponsor

Merck Sharp & Dohme LLC